Melanoma Breakthrough: New Mechanism May Lead to Drug Resistance, Metastasis

EphA2 protein activity increases aggressive behavior of melanoma cells treated with B-Raf inhibitor drugs, but alternate dosing may reign in some of the aggression, Moffitt Cancer Center researchers report.